Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32
cIRcle (University of British Columbia) · 01.01.2023
DOI: 10.14288/1.0437498 ↗Kurz gefasst
Fachartikel in der Zeitschrift cIRcle (University of British Columbia), erschienen am 01.01.2023. Verfasst von Nicole Domański und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Feature Case: Who said what with NSAIDs: Achieving benefit and mitigating risk in the case of possible microscopic colitis. While drug therapy risk cannot be completely eliminated, pharmacists need to consider a risk vs. benefit analysis in their patient assessments and drug therapy treatment decisions. This case highlights the debate between effective pain control and theoretical NSAID risk in a patient with possible microscopic colitis.
Schlagwörter
Zitieren
APA
Domański, N., & Gobis, B. (2023). Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32. cIRcle (University of British Columbia). https://doi.org/10.14288/1.0437498
Vancouver
Domański N, Gobis B. Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32. cIRcle (University of British Columbia). 2023. doi:10.14288/1.0437498
BibTeX
@article{Domaski2023,
author = {Domański, Nicole and Gobis, Barbara},
title = {Our Practice Newsletter : By Pharmacists For Pharmacists. Issue 32},
journal = {cIRcle (University of British Columbia)},
year = {2023},
doi = {10.14288/1.0437498}
}
EUVIMED